Drug Master Files for: HALOBETASOL PROPIONATE
✉ Email this page to a colleague
HALOBETASOL PROPIONATE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
16329 | I | II | 12/16/2002 | SAFC INC | HALOBETASOL PROPIONATE (HBS) |
16856 | A | II | 9/22/2003 | WAVELENGTH ENTERPRISES LTD | HALOBETASOL PROPIONATE |
16861 | A | II | 9/23/2003 | STERLING SPA | HALOBETASOL PROPIONATE |
16944 | I | II | 11/6/2003 | TEVA PHARMACEUTICAL INDUSTRIES LTD | HALOBETASOL PROPIONATE |
16953 | A | II | 11/13/2003 | HOVIONE FARMACIENCIA SA | HALOBETASOL PROPIONATE |
17529 | A | II | 7/14/2004 | TARO PHARMACEUTICAL INDUSTRIES LTD | HALOBETASOL PROPIONATE USP, MICRONIZED |
18566 | A | II | 8/4/2005 | TRIFARMA SPA | HALOBETASOL PROPIONATE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information